2025-09-11 – Press Releases – www.prnewswire.com
SYDNEY, Sept. 11, 2025 /PRNewswire/ — HaemaLogiX Ltd, a clinical stage Australian biotech, developing novel immunotherapies for patients with blood cancers and B-cell diseases, was honoured to be awarded the “Most Promising CAR-T Pipeline in APAC” at the Asia Pacific CGT Excellence…
